PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) ...
After the U.S. Food and Drug Administration announced an investigation into reports of leaks, breakages and other quality issues with China-made plastic syringes, New Jersey-based medical technology ...
PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of insulin injection devices in the world, today announced ...
Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device includes a ...
Diabetes diagnoses rise globally year after year. The International Diabetes Foundation (IDF) reports that 537 million adults are currently living with diabetes. That number will increase sharply over ...
embecta Corp. (embecta) (Nasdaq: EMBC), a global diabetes care company, visits the Nasdaq MarketSite in Times Square today in recognition of National Diabetes Awareness Month in November. embecta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results